BiotechTube
Flow Contract Site Laboratory

Flow Contract Site Laboratory

San Diego, United States· Est.
fcslaboratory.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Founded in 2010 and based in San Diego, Flow Contract Site Laboratory (FCSL) is a CAP-accredited contract lab offering tailored flow cytometry services for the biopharmaceutical industry. Its core capabilities include immunophenotyping, receptor occupancy assays, functional cell-based assays, and PBMC isolation, serving clients globally. In February 2024, FCSL was acquired by Translational Drug Development (TD2), integrating its flow cytometry expertise into a broader oncology-focused drug development ecosystem to provide more comprehensive preclinical and clinical support services.

OncologyImmunology

Technology Platform

CAP-accredited flow cytometry services including custom immunophenotyping, receptor occupancy assays, functional cell-based assays (e.g., NK cell function, Basophil Activation Test), and PBMC isolation. Utilizes Becton Dickinson flow cytometers and offers end-to-service from experimental design to data analysis.

Opportunities

Leverage TD2's integrated oncology platform to cross-sell flow cytometry services to a broader biotech client base.
Capitalize on the growing demand for complex cellular analysis driven by immunotherapies and personalized medicine.
Expand service offerings into new functional assays and technology areas like spectral flow cytometry.

Risk Factors

Integration challenges post-acquisition by TD2 could disrupt operations or culture.
Intense competition from large global CROs and niche flow cytometry labs.
Technological obsolescence requires continuous capital investment in new instruments and methods.

Competitive Landscape

Competes with large, full-service CROs (e.g., LabCorp, IQVIA) that have flow cytometry divisions and with specialized boutique flow cytometry labs. Differentiation is based on deep customization, CAP-accredited clinical trial support, and now, integration with TD2's dedicated oncology development services.

More companies in Diagnostics & Precision Medicine →More companies in United States →